MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen

Although allogeneic hematopoietic cell transplantation (allo-HCT) is the only curative treatment for myelofibrosis (MF), data are limited on how molecular markers predict transplantation outcomes. We retrospectively evaluated transplantation outcomes of 110 consecutive MF patients who underwent allo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Adv
Autori principali: Ali, Haris, Aldoss, Ibrahim, Yang, Dongyun, Mokhtari, Sally, Khaled, Samer, Aribi, Ahmed, Afkhami, Michelle, Al Malki, Monzr M., Cao, Thai, Mei, Matthew, O’Donnell, Margaret, Salhotra, Amandeep, Pullarkat, Vinod, Yang, Lixin, Stein, Anthony S., Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Pillai, Raju, Snyder, David
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2019
Soggetti:
Transplantation
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325305/
https://ncbi.nlm.nih.gov/pubmed/30622146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018026658
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi